Big-name investors pour $100M into DNA therapeutics developer Seawolf
BioPharma DiveJacob BellNovember 16, 2026
The startup, which also just disclosed an up to $1.2 billion partnership with Sanofi, is backed by Versant, MPM BioImpact, Eli Lilly and Novartis venture arm.
